Suitability of conventional systematic vs. MRI-guided targeted biopsy approaches to assess surgical treatment delay for radical prostatectomy

[1]  K. Rahbar,et al.  Precision-guidance vs Systematic Sampling: Optimizing Biopsy Assessment of Secondary Prostate Cancer Suspicious Multiparametric Magnetic Resonance Imaging Lesions , 2022, The Journal of urology.

[2]  Christian Wagner,et al.  Feasibility of robot-assisted radical prostatectomy in men at senior age ≥75 years: perioperative, functional, and oncological outcomes of a high-volume center , 2021, The aging male : the official journal of the International Society for the Study of the Aging Male.

[3]  M. Terris,et al.  Association between Delay to Radical Prostatectomy and Clinically Meaningful Outcomes among Patients with Intermediate and High-Risk Localized Prostate Cancer , 2021, The Journal of urology.

[4]  A. Vickers.  Effects of Magnetic Resonance Imaging Targeting on Overdiagnosis and Overtreatment of Prostate Cancer. , 2021, European urology.

[5]  S. Shariat,et al.  Effects of Delayed Radical Prostatectomy and Active Surveillance on Localised Prostate Cancer—A Systematic Review and Meta-Analysis , 2021, Cancers.

[6]  A. Briganti,et al.  Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review , 2021, World Journal of Urology.

[7]  C. Iselin,et al.  Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic , 2020, World Journal of Urology.

[8]  Z. Savin,et al.  The effect of delaying transperineal fusion biopsy of the prostate for patients with suspicious MRI findings—Implications for the COVID-19 era , 2020, Urologic Oncology: Seminars and Original Investigations.

[9]  A. George,et al.  Delayed Radical Prostatectomy is Not Associated with Adverse Oncological Outcomes: Implications for Men Experiencing Surgical Delay Due to the COVID-19 Pandemic. , 2020, The Journal of urology.

[10]  B. Trock,et al.  Five-year Outcomes of Magnetic Resonance Imaging–based Active Surveillance for Prostate Cancer: A Large Cohort Study , 2020, European urology.

[11]  A. Moinzadeh,et al.  Considerations in the Triage of Urologic Surgeries During the COVID-19 Pandemic , 2020, European Urology.

[12]  P. Choyke,et al.  MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis. , 2020, The New England journal of medicine.

[13]  K. Macura,et al.  Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort. , 2020, European urology.

[14]  M. Cooperberg,et al.  Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT). , 2020, European urology.

[15]  K. Trpkov,et al.  The effect of time from biopsy to radical prostatectomy on adverse pathologic outcomes , 2019, Research and reports in urology.

[16]  G. Muto,et al.  A multicentric study on accurate grading of prostate cancer with systematic and MRI/US fusion targeted biopsies: comparison with final histopathology after radical prostatectomy , 2019, World Journal of Urology.

[17]  D. Nieboer,et al.  Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis. , 2020, European urology.

[18]  S. Fosså,et al.  Is time from diagnosis to radical prostatectomy associated with oncological outcomes? , 2018, World Journal of Urology.

[19]  E. Faria,et al.  Time between diagnosis and surgical treatment on pathological and clinical outcomes in prostate cancer: does it matter? , 2018, World Journal of Urology.

[20]  F. Montorsi,et al.  Evaluating the effect of time from prostate cancer diagnosis to radical prostatectomy on cancer control: Can surgery be postponed safely? , 2017, Urologic oncology.

[21]  A. Haese*,et al.  Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens. , 2016, European urology.

[22]  P. Carroll,et al.  Immediate versus delayed radical prostatectomy: updated outcomes following active surveillance of prostate cancer. , 2015, European urology.

[23]  K. Badani,et al.  Delay from biopsy to radical prostatectomy influences the rate of adverse pathologic outcomes , 2015, The Prostate.

[24]  H. G. van der Poel,et al.  Timing of curative treatment for prostate cancer: a systematic review. , 2013, European urology.

[25]  M. Terris,et al.  Delayed radical prostatectomy for intermediate‐risk prostate cancer is associated with biochemical recurrence: Possible implications for active surveillance from the SEARCH database , 2013, The Prostate.

[26]  Jennifer R. Rider,et al.  Natural history of early, localized prostate cancer: a final report from three decades of follow-up. , 2013, European urology.

[27]  J. McKiernan,et al.  Effect of delaying surgery on radical prostatectomy outcomes: a contemporary analysis , 2012, BJU international.

[28]  L. Holmberg,et al.  Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial. , 2009, European urology.